Video

Exploring Combination Drug Exposure for Epileptic Pregnant Women

Author(s):

Kimford J. Meador, MD speaks about the neurodevelopment effects of combination drug exposure in women with epilepsy at the American Epilepsy Association 2014 Annual Meeting.

Kimford J. Meador, MD speaks about the neurodevelopment effects of combination drug exposure in women with epilepsy at the American Epilepsy Association 2014 Annual Meeting.

Meador commented, "There are a lot of seizure medications that we don't understand the risks or the combinations very well. Most women with epilepsy go through pregnancy on a single drug, but there's a reasonable subset of anywhere from 20-33% of women that are on polytherapy and we don't know those combinations may increase risks."

Related Videos
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
© 2024 MJH Life Sciences

All rights reserved.